Index
1 Fidaxomicin Market Overview
1.1 Fidaxomicin Product Overview
1.2 Fidaxomicin Market Segment by Type
1.2.1 Purity:90%
1.2.2 Purity:95%
1.2.3 Others
1.3 Global Fidaxomicin Market Size by Type
1.3.1 Global Fidaxomicin Market Size Overview by Type (2018-2029)
1.3.2 Global Fidaxomicin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Fidaxomicin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fidaxomicin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Fidaxomicin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Fidaxomicin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Fidaxomicin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Fidaxomicin Sales Breakdown by Type (2018-2023)
2 Global Fidaxomicin Market Competition by Company
2.1 Global Top Players by Fidaxomicin Sales (2018-2023)
2.2 Global Top Players by Fidaxomicin Revenue (2018-2023)
2.3 Global Top Players by Fidaxomicin Price (2018-2023)
2.4 Global Top Manufacturers Fidaxomicin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fidaxomicin Market Competitive Situation and Trends
2.5.1 Fidaxomicin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Fidaxomicin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fidaxomicin as of 2022)
2.7 Date of Key Manufacturers Enter into Fidaxomicin Market
2.8 Key Manufacturers Fidaxomicin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Fidaxomicin Status and Outlook by Region
3.1 Global Fidaxomicin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Fidaxomicin Historic Market Size by Region
3.2.1 Global Fidaxomicin Sales in Volume by Region (2018-2023)
3.2.2 Global Fidaxomicin Sales in Value by Region (2018-2023)
3.2.3 Global Fidaxomicin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Fidaxomicin Forecasted Market Size by Region
3.3.1 Global Fidaxomicin Sales in Volume by Region (2024-2029)
3.3.2 Global Fidaxomicin Sales in Value by Region (2024-2029)
3.3.3 Global Fidaxomicin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Fidaxomicin by Application
4.1 Fidaxomicin Market Segment by Application
4.1.1 Hospital
4.1.2 Retail Pharmacies
4.2 Global Fidaxomicin Market Size by Application
4.2.1 Global Fidaxomicin Market Size Overview by Application (2018-2029)
4.2.2 Global Fidaxomicin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Fidaxomicin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fidaxomicin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Fidaxomicin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Fidaxomicin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Fidaxomicin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Fidaxomicin Sales Breakdown by Application (2018-2023)
5 North America Fidaxomicin by Country
5.1 North America Fidaxomicin Historic Market Size by Country
5.1.1 North America Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Fidaxomicin Sales in Volume by Country (2018-2023)
5.1.3 North America Fidaxomicin Sales in Value by Country (2018-2023)
5.2 North America Fidaxomicin Forecasted Market Size by Country
5.2.1 North America Fidaxomicin Sales in Volume by Country (2024-2029)
5.2.2 North America Fidaxomicin Sales in Value by Country (2024-2029)
6 Europe Fidaxomicin by Country
6.1 Europe Fidaxomicin Historic Market Size by Country
6.1.1 Europe Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Fidaxomicin Sales in Volume by Country (2018-2023)
6.1.3 Europe Fidaxomicin Sales in Value by Country (2018-2023)
6.2 Europe Fidaxomicin Forecasted Market Size by Country
6.2.1 Europe Fidaxomicin Sales in Volume by Country (2024-2029)
6.2.2 Europe Fidaxomicin Sales in Value by Country (2024-2029)
7 Asia-Pacific Fidaxomicin by Region
7.1 Asia-Pacific Fidaxomicin Historic Market Size by Region
7.1.1 Asia-Pacific Fidaxomicin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Fidaxomicin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Fidaxomicin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Fidaxomicin Forecasted Market Size by Region
7.2.1 Asia-Pacific Fidaxomicin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Fidaxomicin Sales in Value by Region (2024-2029)
8 Latin America Fidaxomicin by Country
8.1 Latin America Fidaxomicin Historic Market Size by Country
8.1.1 Latin America Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Fidaxomicin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Fidaxomicin Sales in Value by Country (2018-2023)
8.2 Latin America Fidaxomicin Forecasted Market Size by Country
8.2.1 Latin America Fidaxomicin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Fidaxomicin Sales in Value by Country (2024-2029)
9 Middle East and Africa Fidaxomicin by Country
9.1 Middle East and Africa Fidaxomicin Historic Market Size by Country
9.1.1 Middle East and Africa Fidaxomicin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Fidaxomicin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Fidaxomicin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Fidaxomicin Forecasted Market Size by Country
9.2.1 Middle East and Africa Fidaxomicin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Fidaxomicin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Astellas
10.1.1 Astellas Company Information
10.1.2 Astellas Introduction and Business Overview
10.1.3 Astellas Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Astellas Fidaxomicin Products Offered
10.1.5 Astellas Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Fidaxomicin Products Offered
10.2.5 Merck Recent Development
10.3 Optimer Pharmaceuticals
10.3.1 Optimer Pharmaceuticals Company Information
10.3.2 Optimer Pharmaceuticals Introduction and Business Overview
10.3.3 Optimer Pharmaceuticals Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Optimer Pharmaceuticals Fidaxomicin Products Offered
10.3.5 Optimer Pharmaceuticals Recent Development
10.4 Rochem
10.4.1 Rochem Company Information
10.4.2 Rochem Introduction and Business Overview
10.4.3 Rochem Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Rochem Fidaxomicin Products Offered
10.4.5 Rochem Recent Development
10.5 Tecoland
10.5.1 Tecoland Company Information
10.5.2 Tecoland Introduction and Business Overview
10.5.3 Tecoland Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tecoland Fidaxomicin Products Offered
10.5.5 Tecoland Recent Development
10.6 BrightGene Bio-Medical Technology
10.6.1 BrightGene Bio-Medical Technology Company Information
10.6.2 BrightGene Bio-Medical Technology Introduction and Business Overview
10.6.3 BrightGene Bio-Medical Technology Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BrightGene Bio-Medical Technology Fidaxomicin Products Offered
10.6.5 BrightGene Bio-Medical Technology Recent Development
10.7 Olon
10.7.1 Olon Company Information
10.7.2 Olon Introduction and Business Overview
10.7.3 Olon Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Olon Fidaxomicin Products Offered
10.7.5 Olon Recent Development
10.8 Livzon Group
10.8.1 Livzon Group Company Information
10.8.2 Livzon Group Introduction and Business Overview
10.8.3 Livzon Group Fidaxomicin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Livzon Group Fidaxomicin Products Offered
10.8.5 Livzon Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fidaxomicin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fidaxomicin Industrial Chain Analysis
11.4 Fidaxomicin Market Dynamics
11.4.1 Fidaxomicin Industry Trends
11.4.2 Fidaxomicin Market Drivers
11.4.3 Fidaxomicin Market Challenges
11.4.4 Fidaxomicin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fidaxomicin Distributors
12.3 Fidaxomicin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer